期刊文献+

骨巨细胞瘤中PTEN基因与PCNA的表达 被引量:2

Expression of PTEN gene and PCNA in giant cell tumor of bone
在线阅读 下载PDF
导出
摘要 目的 探讨PTEN与骨巨细胞瘤中破骨样多核巨细胞的关系。方法 采用免疫组化染色方法检测27例骨巨细胞瘤PTEN蛋白与PCNA的表达、PCR检测骨巨细胞瘤PTEN基因的外显子。结果 77 8% (21 /27例)骨巨细胞瘤中仅破骨样多核巨细胞PTEN蛋白呈强表达,PCNA不表达;而间质细胞基本不表达PTEN蛋白,但具有不同比例的PCNA阳性细胞。在所分析的8例骨巨细胞瘤中,PCR均检测到PTEN基因的外显子。结论 PTEN在GCT破骨样多核巨细胞的过表达可能是骨巨细胞瘤形成原因之一。 Purpose To study the relation between PTEN and osteoclast-like multinucleated giant cells in giant tumor cell of bone. Methods Expression of PTEN protein and PCNA in giant cell tumor of bone was detected by immunohistochemistry in 27 cases of giant cell tumor of the bone,and PCR was performed to prove if PTEN gene exists in the tumor. Results Strong expression of PTEN protein was found only in osteoclast-like multinucleated giant cells in 77.8% (21/27 cases) and the gaint cells did not express PCNA. On the contrary,the stromal cells showed high PCNA labeling but almost always PTEN-negative immunohistochemical staining. Extrons of PTEN gene were detected by PCR in all of 8 cases. Conclusions Overexpression of PTEN in osteoclast-like multinucleated giant cells may be one of the histogenetic factors of the giant cell tumor of bone.
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2005年第2期169-172,共4页 Chinese Journal of Clinical and Experimental Pathology
关键词 骨肿瘤 PTEN基因 巨细胞瘤 免疫组织化学 多聚酶链反应 bone neoplasms PTEN gene giant cell tumor,bone immunohistochemistry PCR
  • 相关文献

参考文献22

  • 1郭双平,翟宇强,王文亮,马福成,李华明.肾细胞癌中抑癌基因PTEN的表达及生物学意义[J].临床与实验病理学杂志,2002,18(3):260-263. 被引量:5
  • 2Wulling M,Engels C,Jesse N,et al. The nature of giant cell tumor of bone[J]. J Cancer Res Clin Oncol,2001,127(8):467-74.
  • 3Backman SA,Stambolic V,Suzuki A,et al. Deletion of PTEN in mouse brain causes seizures,ataxia and defects in soma size resembling Lhermitte-Duclos disease[J]. Nat Genet,2001,29(4): 396-403.
  • 4Kwon CH,Zhu X,Zhang J, et al. PTEN regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease[J]. Nat Genet,2001,29(4): 404-11.
  • 5Crackower MA,Oudit GY,Kozieradzki I,et al. Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways[J]. Cell,2002,110(6):737-49.
  • 6Feilotter HE,Nagai MA,Boag AH,et al. Analysis of PTEN and the 10q23 region in primary prostate carcinomas[J]. Oncogene,1998,16(13):1743-8.
  • 7Anthony R,Bharat J,Andre JB, et al. Study of interlaboratory reliability and reproducibility of estrogen and progesterone receptor assays in Europe[J]. Am J Clin Pathol,2001,115(1):44-58.
  • 8Gross-Bellard M,Oudet P,Chambon P. Isolation of high-molecular-weight DNA from mammalian cells[J]. Eur J Biochem,1973,36(1):32-8.
  • 9Abbott RT,Tripp S,Perkins SL,et al. Analysis of the PI-3-Kinase-PTEN-AKT pathway in human lymphoma and leukemia using a cell line microarray[J]. Mod Pathol,2003,16(6): 607-12.
  • 10Srivastava G,Wong KY,Chiang AK,et al. Coinfection of multiple strains of Epstein-Barr virus in immunocompetent normal individuals: reassessment of the viral carrier state[J]. Blood,2000,95(7) : 2443-5.

二级参考文献15

  • 1张志谦,林仲翔.连接蛋白家族、细胞间隙连接通讯与肿瘤抑制[J].生理科学进展,1994,25(2):121-125. 被引量:8
  • 2[1]Maehama T,Dixon JE.The tumor suppressor,PTEN/MMAC1,dephosphorylates the lipid second messenger phosphatidylinositol 3,4,5-triphosphate.J Biol Chem,1998,273:13375.
  • 3[2]Ramaswamy S,Nakarrutra N,Vazquez F,et al.Regulation of G1progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway.Proc Natl Acad Sci USA,1999,96:2110.
  • 4[3]Cains P,Okami K,Halachmi N,et al.Frequent inactivation of PTEN/MMAC1 in primary prostate cancer.Cancer Res,1997,57:4997.
  • 5[4]Vlietstra RJ,van-Alewijk DC,Hermans KG,et al.Frequent inactivation of PTEN in prostate cancer cell lines and xenografts.Cancer Res,1998,58:2720.
  • 6[5]Wang YE,Wu X,Suzuki H,et al.Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression.Proc Natl Acad Sci USA,1998,95:5246.
  • 7[6]DongJT,Li CL,Sipe TW,etal.Mutation of PTEN/MMAC1 in primary prostate cancer from Chinese patient.Clin Cancer Res,2001,7:304.
  • 8[7]Rasheed BK,Stenzel TT,Melendon RE,et al.PTEN gene mutation are seen in high-grade but not in low-grade gliomas.Cancer Res,1997,57:4187.
  • 9[8]Suzuki H,Freije D,Nusskem DR,et al.Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues.Cancer Res,1998,58:204.
  • 10[9]Cairns P,Evron E,Okami K,et al.Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancer.Oncogene,1998,16:3215.

共引文献10

同被引文献36

  • 1李琼,吴明富,宋安萍,魏军成,徐刚,卢运萍,马丁.浸润性乳腺导管癌组织中Ezrin和钙粘素E的表达与淋巴结转移的关系[J].癌症,2006,25(3):363-366. 被引量:53
  • 2李东娅,章晓梅,唐莉.S100蛋白与相关疾病[J].医学研究杂志,2007,36(9):95-97. 被引量:8
  • 3Bruce B, Khanna G,Ren L,et al. Expression of the cytoskele- ton linker protein ezrin in human cancers[J]. Clin Exp Metas- tasis, 2007,24 (2): 69-78.
  • 4Bassiony AA, Abdelrahman M, Abdelhady A, et al. Resection arthrodesis for the management of aggressive giant cell tumor of the distalfemur[J]. Indian J Orthop,2009,43(1 ) :67-71.
  • 5Yu Y, Khan J, Khanna C, et al. Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeo- protein Six 1 as key metastatic regulators[J]. Nat Med,2004, 10(2) : 175-81.
  • 6Mallikariuna K, Pushparaj V, Biswas J, et al. Expression of epi- dermal growth factor receptor, ezrin, hepatocyte growth factor, and c-Met in uveal melanoma: an immunohistochemical study [J].Curr Eye Res,2007,32(3):281- 90.
  • 7Orian-Rousseau V, Morrison H, Matzke A, et al. Hepatocyte growth factor-induced Ras activation requires ERM proteins linked to both CD44v6 andF-actin[J]. Mol Biol Cell, 211117,18( 1 ):76 -83.
  • 8Elliott BE,Meens JA,SenGupta SK,et al. The membrane cy- toskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells[J]. Breast Cancer Res,2005,7(3) :R365-73.
  • 9Khanna C,Wan X, Bose S, et al. The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis[J]. Nat Med, 2004,10 (2) : 182-6.
  • 10Rosman DS,Phukan S, Huang CC, et al. TGFBRI * 6A enhances the migration and invasion of MCF 7 breast cancer cells through RhoA activation[J]. Cancer Res, 2008,68 ( 5 ) : 1319-28.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部